NO20000079L - Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav - Google Patents

Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav

Info

Publication number
NO20000079L
NO20000079L NO20000079A NO20000079A NO20000079L NO 20000079 L NO20000079 L NO 20000079L NO 20000079 A NO20000079 A NO 20000079A NO 20000079 A NO20000079 A NO 20000079A NO 20000079 L NO20000079 L NO 20000079L
Authority
NO
Norway
Prior art keywords
ancrod
mixtures
derivatives
monoclonal antibodies
antibody fragments
Prior art date
Application number
NO20000079A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000079D0 (no
Inventor
Thomas Subkowski
Wilfried Hornberger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20000079D0 publication Critical patent/NO20000079D0/no
Publication of NO20000079L publication Critical patent/NO20000079L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20000079A 1997-07-10 2000-01-07 Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav NO20000079L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19729544A DE19729544A1 (de) 1997-07-10 1997-07-10 Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung
PCT/EP1998/003834 WO1999002564A2 (de) 1997-07-10 1998-06-23 Ancrod spezifische monoklonale antikörper, antikörperfragmente, deren mischungen oder derivate und deren verwendung

Publications (2)

Publication Number Publication Date
NO20000079D0 NO20000079D0 (no) 2000-01-07
NO20000079L true NO20000079L (no) 2000-03-07

Family

ID=7835268

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000079A NO20000079L (no) 1997-07-10 2000-01-07 Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav

Country Status (14)

Country Link
US (1) US6365155B1 (cs)
EP (1) EP1000087A2 (cs)
JP (1) JP2002511880A (cs)
KR (1) KR20010021649A (cs)
CN (1) CN1262690A (cs)
AU (1) AU748841B2 (cs)
BR (1) BR9810574A (cs)
CA (1) CA2295218A1 (cs)
CZ (1) CZ297216B6 (cs)
DE (1) DE19729544A1 (cs)
IL (1) IL133224A0 (cs)
NO (1) NO20000079L (cs)
WO (1) WO1999002564A2 (cs)
ZA (1) ZA986064B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI513466B (zh) * 2010-01-20 2015-12-21 Boehringer Ingelheim Int 抗凝血劑解毒劑

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3841736A1 (de) 1988-12-10 1990-07-05 Basf Ag Ancrod-proteine, ihre herstellung und verwendung
CA2015127A1 (en) * 1989-04-26 1990-10-26 John G. Gray, Jr. Novel dna sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof
DK0556906T3 (da) * 1992-02-17 1996-09-02 Akzo Nobel Nv Kalibrator og dens anvendelse til en immunanalyse
US5523292A (en) * 1992-10-14 1996-06-04 Schwartz; Robert Method of preventing restenosis following coronary angioplasty

Also Published As

Publication number Publication date
CA2295218A1 (en) 1999-01-21
EP1000087A2 (de) 2000-05-17
US6365155B1 (en) 2002-04-02
AU748841B2 (en) 2002-06-13
CZ297216B6 (cs) 2006-10-11
WO1999002564A2 (de) 1999-01-21
JP2002511880A (ja) 2002-04-16
DE19729544A1 (de) 1999-01-14
CN1262690A (zh) 2000-08-09
ZA986064B (en) 2000-01-10
CZ200057A3 (cs) 2000-05-17
KR20010021649A (ko) 2001-03-15
BR9810574A (pt) 2000-09-19
WO1999002564A3 (de) 1999-04-01
NO20000079D0 (no) 2000-01-07
IL133224A0 (en) 2001-03-19
AU8540698A (en) 1999-02-08

Similar Documents

Publication Publication Date Title
EP1071458A4 (en) HUMANIZED ANTIBODIES AND CORRESPONDING USES THEREOF
TR199501614A2 (tr) Anti-alfa integrin monoklonal antikor.
DK0941344T3 (da) Humaniserede anti-CD11a-antistoffer
DE69920897D1 (de) Monoklonale antikörper mit verringerter immunisierungsfähigkeit
NO962346D0 (no) Humaniserte antistoffer og anvendelser derav
IS4892A (is) Styrkt mótefnisblanda
FI964845L (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
CY2005008I1 (el) Αντισωματα αντι - vegf
DE69617896D1 (de) Humaner monoklonaler Antikörper gegen VEGF
FI963004L (fi) Vasta-aineen muodostumista kiihottavia monoklonaalivasta-aineita
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
NO986050L (no) Renset overflateantigen, monoklonalt antistoff fra spermier og anvendelse derav
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
FI914908A0 (fi) Ny monoklonal antikropp med ny antigen relaterad till humana tumoerer.
DE69738312D1 (de) Hepatitis b monoklonale antikörper
HUP0103152A3 (en) Monoclonal antibodies directed against the g3bp protein, and uses
FI972430L (fi) Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja
BR9606978A (pt) Anticorpos monoclonais antiidiótipos (ab2) e usos dos mesmos
GB9718911D0 (en) Monoclonal antibodies
DE3888604D1 (de) Monoklonale Antikörper gegen Antithrombinbindende Substanz und seine Verwendungen.
NO20011006D0 (no) Høy-affinitets antistoffer
NO20000079D0 (no) Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav
EP1071327A4 (en) AUTOANTIGENT FRAGMENTS, METHODS AND ASSAYS
HUP0003029A3 (en) Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same
DE69020315D1 (de) Monoklonaler antikörper gegen c-reaktives protein.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application